Exhibitor Focus: Scope

7. Scope Logo

New DPC2018 exhibitor Scope introduces its ophthalmic products for dry eye disease, a high risk for people with diabetes.

What does your company do?

Scope offers innovative ocular surface disease diagnostic and management products for dry eye and blepharitis. We operate in both the United Kingdom and Ireland, and ensure our product offerings are well-established with a track record of successfully treating patients worldwide.

Our ophthalmics portfolio includes: Hylo Range®, Blephex, ComplEye (eye drop dispenser), OPTASE® Moist Heat Mask, OPTASE® Tea Tree Oil Lid Wipes, Omega Eye, TearLab®, VitA-POS®, Ketofall and Prokera®.

Why is your company working in diabetes care? 

Diabetes raises a person’s chances of getting dry eyes, and more than half of all people with diabetes also have dry eyes. Nerve disease (neuropathy) is also a common complication of diabetes: this nerve damage can hinder a person’s ability to make tears and slow down blinking, causing tears to evaporate.

How is your company improving diabetes care?   

Scope provides products to combat the effect diabetes creates on the ocular surface.

What are you hoping to achieve through your support of DPC2018 and presence at the show? 

Scope hopes to educate the audience on the best form of treatment for dry eye disease, based on the severity of the patient’s condition.


Posted in